Hoth Therapeutics, Inc. — Director's Dealing 2021

Feb 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2021-01-29

Reporting Person: Knie Robb (Director, CEO and President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-29	Options	$2.11	A	225000	Acquired	2031-01-29	Common Stock (225000)	Direct

Footnotes

F1: The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.